- CA$17.07m
- CA$16.08m
- $13.33m
- 57
- 54
- 37
- 47
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.52 | 7.15 | 12.5 | 15.1 | 13.3 |
Cost of Revenue | |||||
Gross Profit | 1.74 | 3.35 | 5.33 | 5.12 | 4.93 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 20.1 | 7.13 | 12.4 | 16.5 | 15.4 |
Operating Profit | -15.5 | 0.015 | 0.036 | -1.38 | -2.04 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -15.5 | 0.049 | 0.026 | -1.5 | -2.04 |
Provision for Income Taxes | |||||
Net Income After Taxes | -14.7 | 0.104 | -0.19 | -1.35 | -2.01 |
Net Income Before Extraordinary Items | |||||
Net Income | -14.7 | 0.104 | -0.19 | -1.35 | -2.01 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14.7 | 0.104 | -0.19 | -1.35 | -2.01 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.045 | 0.001 | -0.001 | -0.01 | -0.015 |